학술논문
Molecular pathology and potential therapeutic targets in soft-tissue sarcoma
Document Type
Clinical report
Author
Source
Expert Review of Anticancer Therapy. June 2008, Vol. 8 Issue 6, p939, 10 p.
Subject
Language
English
ISSN
1473-7140
Abstract
Author(s): Radha Todd [sup.1] , John Lunec [sup.[[dagger]]] [sup.2] Keywords : molecular pathology; soft-tissue sarcoma; therapy The soft-tissue sarcomas (STSs) are a diverse group of rare tumors that account for [...]
The soft-tissue sarcomas are a diverse group of rare malignancies of mesenchymal tissue. Surgery is the principle modality of treatment but chemotherapy is used for the treatment of advanced or metastatic tumors. However, the response to chemotherapy is poor. Genetic factors are known to be important in the development of soft-tissue sarcomas and also have a role in response to treatment. This review discusses known genetic abnormalities in soft-tissue sarcomas. Molecular targets for treatment are also discussed along with a review of treatments that have been developed to date.
The soft-tissue sarcomas are a diverse group of rare malignancies of mesenchymal tissue. Surgery is the principle modality of treatment but chemotherapy is used for the treatment of advanced or metastatic tumors. However, the response to chemotherapy is poor. Genetic factors are known to be important in the development of soft-tissue sarcomas and also have a role in response to treatment. This review discusses known genetic abnormalities in soft-tissue sarcomas. Molecular targets for treatment are also discussed along with a review of treatments that have been developed to date.